Metastatic Hormone Sensitive Prostate Cancer With High Tumor Load clinical trials

Explore recruiting metastatic hormone sensitive prostate cancer with high tumor load clinical trials.

Recruiting metastatic hormone sensitive prostate cancer with high tumor load studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Metastatic Hormone Sensitive Prostate Cancer With High Tumor Load trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

One multicenter, randomized, open, phase III clinical study on SHR3680 combined with androgen deprived therapy (ADT) versus Bicalutamide combined with ADT in treatment of metastatic hormone-sensitive prostate cancer with high tumor load.

Czechia, Bulgaria, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Metastatic Hormone Sensitive Prostate Cancer With High Tumor Load trials by city

Metastatic Hormone Sensitive Prostate Cancer With High Tumor Load in Toronto Metastatic Hormone Sensitive Prostate Cancer With High Tumor Load in Vancouver Metastatic Hormone Sensitive Prostate Cancer With High Tumor Load in Montreal Metastatic Hormone Sensitive Prostate Cancer With High Tumor Load in Calgary Metastatic Hormone Sensitive Prostate Cancer With High Tumor Load in Edmonton Metastatic Hormone Sensitive Prostate Cancer With High Tumor Load in Ottawa Metastatic Hormone Sensitive Prostate Cancer With High Tumor Load in Winnipeg Metastatic Hormone Sensitive Prostate Cancer With High Tumor Load in Quebec City Metastatic Hormone Sensitive Prostate Cancer With High Tumor Load in Hamilton Metastatic Hormone Sensitive Prostate Cancer With High Tumor Load in Kitchener Metastatic Hormone Sensitive Prostate Cancer With High Tumor Load in London Metastatic Hormone Sensitive Prostate Cancer With High Tumor Load in Halifax Metastatic Hormone Sensitive Prostate Cancer With High Tumor Load in New York Metastatic Hormone Sensitive Prostate Cancer With High Tumor Load in Los Angeles Metastatic Hormone Sensitive Prostate Cancer With High Tumor Load in Chicago Metastatic Hormone Sensitive Prostate Cancer With High Tumor Load in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease